Leading Innovation in Cancer Screening
Frontier Diagnostics are advancing the early detection and monitoring of cancer through scientific expertise and AI-powered laboratory technology.
£10,000 Minimum Investment
Now in the 3rd year of trading and taking orders worldwide delve deeper this exciting groundbreaking venture. Secure your EIS-approved investment guide now and discover how your contribution can reshape the landscape of cancer care.
Investment Highlights:

Frontier Diagnostics is driving the next generation of cancer screening through scientific expertise and clinical innovation.

Our mission is simple – to transform how cancer is detected, diagnosed, and monitored through cutting-edge laboratory technology and AI-powered blood tests.

  • ISO-accredited laboratory infrastructure with rapid testing capability
  • In-house Quantum Fluoroscope device for next-generation diagnostics
  • Established UK & European operations with near-term global expansion
  • AI-powered tools supporting clinicians & patients across treatment cycles
  • Targeting 7x–10x investor returns based on projected growth and market expansion
GET MORE INFORMATION
EIS Benefits:
  • Receive up to 30% income tax relief on investment.
  • Defer or eliminate capital gains on qualifying shares along with loss relief
  • Benefit from inheritance tax exemption after holding two years

Outstanding opportunity to support a UK-based biotech company focused on improving and potentially extending lives through early detection and diagnosis

GET MORE INFORMATION

Disclaimer: Any person accessing this website or page and considering potential investment opportunities featured here, should make their own commercial assessment of an investment opportunity after seeking the advice of an appropriately authorised or regulated financial advisor. This website or page should not be construed as advice or a personal recommendation to any prospective investor. Investments of this nature carry risks to your capital and can go up or down. Past performance is not indicative of future results. Suitable appropriately qualified investors, sophisticated and high net worth investors only.

Privacy Policy